<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00172575</url>
  </required_header>
  <id_info>
    <org_study_id>9361701184</org_study_id>
    <nct_id>NCT00172575</nct_id>
  </id_info>
  <brief_title>Differentiation of Malig. &amp; Ben. Solitary Pulm. Nodules &amp; Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of our study is to determine whether contrast-enhanced dynamic MRI (DCE MRI)&#xD;
      analysis of tumor angiogenesis and perfusion can be used as a reliable modality to&#xD;
      differentiate benign from malignant solitary pulmonary nodules (SPN) before surgical&#xD;
      intervention, using kinetic model derived from DCE MRI, and further correlate if there is any&#xD;
      positive correlation between angiogenesis factor (vascular endothelial growth factor VEGF,&#xD;
      microvessel density MVD); and if the perfusion parameters from DCE MRI can predict patients'&#xD;
      outcomes and survival.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The solitary pulmonary nodule (SPN) is a common finding in chest radiography. Pulmonary&#xD;
      nodules larger than 1cm indicative of malignancy or with indeterminate finding according to&#xD;
      morphology criteria have to be defined by invasive methods such as biopsy or surgical&#xD;
      excision, and benign pathology makes up 20-50% of those resected pulmonary lesions. The&#xD;
      lesions not receiving surgical intervention often need imaging follow-up on a regular basis&#xD;
      for a long period of time to monitor the stability of the finding.&#xD;
&#xD;
      There are many reports regarding the MRI perfusion analysis of neoplasms from many organs,&#xD;
      including bone marrow, liver, breast, cervix, and they stressed not only on comparison&#xD;
      between benignity and malignancy, but also on monitoring the treatment outcomes after&#xD;
      neoadjuvant chemotherapy, radiation therapy or anti-angiogenic agent therapy [7-15]. Dynamic&#xD;
      contrast-enhanced MRI (DCE MRI) is not a standard examination for SPN, but there have been&#xD;
      some data regarding the differentiation between malignant and benign SPN using DCE MRI, with&#xD;
      MRI offering higher specificity compared to dynamic CT scan [6, 7, 16]. It was also reported&#xD;
      that DCE MRI could delineate kinetic and morphologic differences in tumor angiogenesis and&#xD;
      perfusion characteristics between malignant and benign pulmonary lesions with relatively high&#xD;
      accuracy [7, 16]. The purpose of our study is to determine whether DCE MRI analysis of tumor&#xD;
      angiogenesis and perfusion can be used as a reliable modality to differentiate benign from&#xD;
      malignant SPN before surgical intervention, using kinetic model derived from DCE MRI, and&#xD;
      further correlate if there is any positive correlation between angiogenesis factor (vascular&#xD;
      endothelial growth factor VEGF, microvessel density MVD); and if the perfusion parameters&#xD;
      from DCE MRI can predict patients' outcomes and survival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2004</start_date>
  <completion_date>December 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment>60</enrollment>
  <condition>Lung Neoplasms</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who have solitary pulmonary nodules in CT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who don't fit the above inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pan-Chyr Yang, PhD</last_name>
    <role>Study Director</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tiffany Ting-Fang Shih, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jane Wang, MD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>5565</phone_ext>
    <email>hstjen@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Wang, MD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>5565</phone_ext>
      <email>hstjen@yahoo.com.tw</email>
    </contact>
    <investigator>
      <last_name>Jane Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tiffany Ting-Fang Shih, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Schaefer JF, Vollmar J, Schick F, Vonthein R, Seemann MD, Aebert H, Dierkesmann R, Friedel G, Claussen CD. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions. Radiology. 2004 Aug;232(2):544-53. Epub 2004 Jun 23.</citation>
    <PMID>15215548</PMID>
  </reference>
  <reference>
    <citation>Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon OJ, Jeong YJ, Kim S. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology. 2004 Oct;233(1):191-9. Epub 2004 Aug 10.</citation>
    <PMID>15304661</PMID>
  </reference>
  <verification_date>December 2004</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>September 12, 2005</last_update_submitted>
  <last_update_submitted_qc>September 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2005</last_update_posted>
  <keyword>Lung neoplasms</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

